Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Adc Therapeutics Sa (ADCT)

Adc Therapeutics Sa (ADCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 284,753
  • Shares Outstanding, K 82,777
  • Annual Sales, $ 69,560 K
  • Annual Income, $ -240,050 K
  • 60-Month Beta 1.59
  • Price/Sales 4.37
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade ADCT with:

Options Overview Details

View History
  • Implied Volatility 57.31% ( -15.97%)
  • Historical Volatility 121.83%
  • IV Percentile 5%
  • IV Rank 4.30%
  • IV High 833.12% on 11/09/23
  • IV Low 22.45% on 05/23/24
  • Put/Call Vol Ratio 0.00
  • Today's Volume 281
  • Volume Avg (30-Day) 119
  • Put/Call OI Ratio 0.31
  • Today's Open Interest 1,889
  • Open Int (30-Day) 5,903

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/24
See More
  • Average Estimate -0.42
  • Number of Estimates 4
  • High Estimate -0.37
  • Low Estimate -0.48
  • Prior Year -0.58
  • Growth Rate Est. (year over year) +27.59%

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.45 +48.54%
on 06/26/24
4.13 -11.86%
on 07/16/24
+0.99 (+37.36%)
since 06/21/24
3-Month
2.45 +48.54%
on 06/26/24
5.17 -29.59%
on 05/06/24
-1.04 (-22.22%)
since 04/22/24
52-Week
0.36 +911.39%
on 11/13/23
6.04 -39.74%
on 02/20/24
+2.22 (+156.34%)
since 07/21/23

Most Recent Stories

More News
5 Biotech Stocks Under $10 With Multibagger Potential

As the biotech industry continues to redefine the healthcare landscape, here are five penny biotech stocks poised for meteoric growth in this evolving industry.

ADCT : 3.64 (+5.81%)
$SPX : 5,564.41 (+1.08%)
RZLT : 4.67 (+3.32%)
TRVI : 2.81 (+1.08%)
ELEV : 2.71 (+2.65%)
CRDL : 2.22 (+6.22%)
1 'Strong Buy' Russell 2000 Stock With 188% Upside Potential

As a part of the annual Russell Index reconstitution, this ‘Strong Buy’-rated penny stock is one of the new entrants to the Russell 2000 Index.

ADCT : 3.64 (+5.81%)
$SPX : 5,564.41 (+1.08%)
MRSN : 2.0000 (+1.52%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ADC Therapeutics SA - ADCT

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of ADC Therapeutics SA ("ADC" or the "Company") (NYSE: ADCT). Such investors are...

ADCT : 3.64 (+5.81%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ADC Therapeutics SA - ADCT

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of ADC Therapeutics SA ("ADC" or the "Company") (NYSE: ADCT). Such investors are...

ADCT : 3.64 (+5.81%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ADC Therapeutics SA - ADCT

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of ADC Therapeutics SA ("ADC" or the "Company") (NYSE: ADCT). Such investors are...

ADCT : 3.64 (+5.81%)
Sobi to present new data at the 2023 EHA congress

/PRNewswire/ -- Sobi® will present data at the EHA (European Haematology Association) hybrid congress taking place in Frankfurt, Germany 8-11 June, 2023,...

ADCT : 3.64 (+5.81%)
ADC Therapeutics to Host First Quarter 2023 Financial Results Conference Call on May 9, 2023

ADC Therapeutics SA (NYSE: ADCT) today announced that it will host a conference call and live webcast on Tuesday, May 9, 2023 at 8:30 a.m. EDT to report financial results for the first quarter 2023 and...

ADCT : 3.64 (+5.81%)
PharmaVentures establishes an office in Seoul to enhance access for South Korean biotechs

/PRNewswire/ -- PharmaVentures announces its new office in Korea as part of its continued strategic expansion Headquartered in London, UK, PharmaVentures has...

ADCT : 3.64 (+5.81%)
ADC Therapeutics Releases its Annual Report on Form 20-F for the Fiscal Year Ended December 31, 2022

ADC Therapeutics SA (NYSE: ADCT) today announced its Annual Report on Form 20-F for the fiscal year ended December 31, 2022, has been filed with the U.S. Securities and Exchange Commission (the “SEC”)....

ADCT : 3.64 (+5.81%)
ADC Therapeutics to Participate in the Cowen 43rd Annual Health Care Conference

ADC Therapeutics SA (NYSE: ADCT) announced today that Ameet Mallik, Chief Executive Officer, will present a company overview at the Cowen 43 rd Annual Health Care Conference in Boston, MA, on Tuesday,...

ADCT : 3.64 (+5.81%)

Business Summary

ADC Therapeutics SA is a late clinical-stage oncology-focused biotechnology company. It engages in development and commercialization of antibody drug conjugates for patients suffering from hematological malignancies and solid tumors. ADC Therapeutics SA is based in LAUSANNE, Switzerland.

See More

Key Turning Points

3rd Resistance Point 4.09
2nd Resistance Point 3.88
1st Resistance Point 3.76
Last Price 3.64
1st Support Level 3.43
2nd Support Level 3.22
3rd Support Level 3.10

See More

52-Week High 6.04
Fibonacci 61.8% 3.87
Last Price 3.64
Fibonacci 50% 3.20
Fibonacci 38.2% 2.53
52-Week Low 0.36

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar